Page last updated: 2024-08-24

squaric acid dibutyl ester and Alopecia Circumscripta

squaric acid dibutyl ester has been researched along with Alopecia Circumscripta in 80 studies

Research

Studies (80)

TimeframeStudies, this research(%)All Research%
pre-199028 (35.00)18.7374
1990's22 (27.50)18.2507
2000's16 (20.00)29.6817
2010's10 (12.50)24.3611
2020's4 (5.00)2.80

Authors

AuthorsStudies
Losol, E; Şentürk, N1
Hide, M; Numata, T; Takahagi, S; Tanaka, A1
Alessandrini, A; Bruni, F; Carpanese, MA; Misciali, C; Piraccini, BM; Sechi, A; Starace, M; Vezzoni, R1
Kim, BJ; Lee, S; Lee, WS; Lee, YB1
Gómez-Flores, M; Herz-Ruelas, ME; Lozano-Peña, AK; Ocampo-Candiani, J; Vázquez-Martínez, O; Welsh-Lozano, O1
Shapiro, J2
Adachi, T; Ebihara, T; Ohyama, M; Ouchi, T1
Avitabile, S; Cavani, A; Colonna, L; De Luca, A; Garcovich, S; Mazzanti, C; Nasorri, F; Sordi, D1
Kroshinsky, D; Vedak, P1
Furukawa, F; Yoshimasu, T1
Angelo, C; Calabresi, V; Castiglia, D; De Luca, N; Di Zenzo, G; Guerra, L; Pacifico, V; Zambruno, G1
Carlberg, V; Chen, CA; Kroshinsky, D1
Inui, S; Itami, S; Nakajima, T; Toda, N1
Burkhart, CN; Morrell, DS; Mukherjee, N1
Freyschmidt-Paul, P; Mueller, U; Singh, V; Zöller, M1
Ito, T; Tokura, Y1
Kishi, T; Miyachi, Y; Morita, K; Nagamachi, M; Nakamura, M1
Chin Giam, Y; Goh, CL; Tan, E; Tay, YK1
Misciali, C; Piraccini, BM; Tosti, A; Vincenzi, C1
Freyschmidt-Paul, P; Hoffmann, R; Hummel, S; McElwee, KJ; Vitacolonna, M; Zöller, M1
Henderson, RL; McMichael, AJ1
Dall'oglio, F; La Torre, G; Micali, G; Musumeci, ML; Nasca, MR; Potenza, C; Ricciardi, G1
Sawamura, D; Shibaki, A; Shimizu, H; Ujiie, H1
Ajith, C; Gupta, S; Kanwar, AJ1
Freyschmidt-Paul, P; Gupta, P; Hildebrand, D; Hummel, S; Kiessling, S; Marhaba, R; Vitacolonna, M; Zöller, M1
Baniyash, M; Freyschmidt-Paul, P; Hildebrand, D; Marhaba, R; Vitacolonna, M; Zöller, M1
Hamasaki, Y; Hatamochi, A; Ikeda, H; Shimaoka, Y; Suzuki, H; Yamazaki, S1
Mato, F; Miranda, A; Quiñones, PA1
Giannetti, A; Orecchia, G1
Case, PC; Ellis, CN; Headington, JT; Mitchell, AJ; Swanson, NA; Vanderveen, EE1
Fenske, NA; Flowers, FP; Pullara, TJ; Slazinski, L1
Büchner, U; Echternacht-Happle, K; Göggelmann, W; Happle, R; Kalveram, KJ; Summer, KH1
Malagoli, P; Orecchia, G1
Bardazzi, F; Cameli, N; Fanti, PA; Guerra, L; Morelli, R; Tosti, A1
Malagoli, P; Orecchia, G; Santagostino, L1
Happle, R; van der Steen, PH1
Cicero, RL; Innocenzi, D; Micali, G; Nasca, MR1
Bardazzi, F; Guidetti, MS; Misciali, C; Tosti, A1
Cicero, RL; Micali, G; Nasca, MR; Sapuppo, A1
Ang, CB; Chua, SH; Goh, CL1
Cargnello, S; Frattasio, A; Germino, M; Patrone, P1
Iijima, S; Otsuka, F1
Licastro Cicero, R; Micali, G; Nasca, MR; Pulvirenti, N1
Rokhsar, CK; Shupack, JL; Vafai, JJ; Washenik, K1
Buckley, DA; du Vivier, AW1
Boggess, D; Freyschmidt-Paul, P; Happle, R; Hoffmann, R; McElwee, KJ; Metz, S; Sundberg, JP1
Patrone, P; Stinco, G1
Freyschmidt-Paul, P; Gardner, S; Happle, R; Hoffmann, R; Lindsey, NJ; Sundberg, JP; Tobin, DJ1
McMichael, AJ; Pardasani, AG; Turner, E1
Boezeman, JB; Happle, R; van der Steen, PH1
Bigardi, A; Pigatto, PD; Rossi, A; Valsecchi, R1
Bröcker, EB; Hamm, H; John, SM; Steinhausen, D1
Happle, R; Perret, CM; Steijlen, PM; Zaun, H1
Cainelli, T; Naldi, L; Parazzini, F1
Borroni, G; Orecchia, G; Perfetti, L; Rabbiosi, G1
Marelli, MA; Orecchia, G; Perfetti, L; Rabbiosi, G1
Cainelli, T; Foiadelli, L; Rossi, A; Valsecchi, R1
Johansson, E; Kianto, U; Niemi, KM; Ranki, A; Reunala, T1
Happle, R; Perret, CM; Steijlen, PM1
Orecchia, G2
Bardazzi, F; Guerra, L; Tosti, A1
Gasponi, A; Manuzzi, P; Tosti, A1
Brasile, GP; Capobianco, C; Guerra, L; Tosti, A1
Douville, H; Marelli, MA; Orecchia, G; Paulli, M; Rosso, R1
Capelli, E; Cuccia Belvedere, M; Martinetti, M; Orecchia, G; Rabbiosi, G1
Caserio, RJ1
Altomare, GF; Pigatto, PD; Polenghi, MM; Rapisarda, R1
Sherertz, EF; Sloan, KB1
Orecchia, G; Rabbiosi, G2
Bardazzi, F; Ghetti, P; Tosti, A1
De Padova, MP; Minghetti, G; Tosti, A; Veronesi, S1
Morishita, M; Nagai, T; Sato, Y1
Barth, JH; Darley, CR; Gibson, JR2
Cainelli, T; Panunzio, M; Perego, GB; Rossi, A; Smojver, E; Tornaghi, A; Valsecchi, R1
Cainelli, T; Valsecchi, R1
Henkin, J; Smith, RG; Wilkerson, MG; Wilkin, JK1

Reviews

10 review(s) available for squaric acid dibutyl ester and Alopecia Circumscripta

ArticleYear
Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
    JAMA dermatology, 2018, 10-01, Volume: 154, Issue:10

    Topics: Adjuvants, Immunologic; Alopecia; Alopecia Areata; Cyclobutanes; Cyclopropanes; Hair; Humans; Immunotherapy; Recurrence

2018
Current treatment of alopecia areata.
    The journal of investigative dermatology. Symposium proceedings, 2013, Volume: 16, Issue:1

    Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Alopecia Areata; Anthralin; Cyclobutanes; Cyclopropanes; Cyclosporine; Dermatologic Agents; Humans; Immunosuppressive Agents; Injections, Intralesional; Methotrexate; Minoxidil; PUVA Therapy; Self-Help Groups

2013
Modified immunotherapy for alopecia areata.
    Autoimmunity reviews, 2016, Volume: 15, Issue:7

    Topics: Adjuvants, Immunologic; Alopecia Areata; Autoimmunity; Combined Modality Therapy; Cyclobutanes; Humans; Immunotherapy

2016
Treatment of alopecia areata in children.
    Pediatric annals, 2009, Volume: 38, Issue:7

    Topics: Adjuvants, Immunologic; Administration, Cutaneous; Alopecia Areata; Anthralin; Child; Child, Preschool; Cyclobutanes; Cyclopropanes; Dermatologic Agents; Dinitrochlorobenzene; Glucocorticoids; Humans; Immunosuppressive Agents; Immunotherapy; Minoxidil; Phototherapy; Practice Guidelines as Topic; Treatment Outcome; Vasodilator Agents

2009
Topical sensitizers in alopecia areata.
    Dermatology nursing, 2004, Volume: 16, Issue:4

    Topics: Adjuvants, Immunologic; Administration, Cutaneous; Alopecia Areata; Cyclobutanes; Cyclopropanes; Dinitrochlorobenzene; Humans; Inflammation; Irritants; Patient Selection; Prognosis; Severity of Illness Index; Treatment Outcome

2004
Topical immunotherapy in the treatment of chronic severe alopecia areata.
    Dermatologic clinics, 1993, Volume: 11, Issue:3

    Topics: Administration, Topical; Allergens; Alopecia Areata; Chronic Disease; Cyclobutanes; Cyclopropanes; Dinitrochlorobenzene; Hair; Humans; Immunotherapy

1993
Efficacy of topical sensitizers in the treatment of alopecia areata.
    Journal of the American Academy of Dermatology, 1998, Volume: 39, Issue:5 Pt 1

    Topics: Adjuvants, Immunologic; Administration, Cutaneous; Alopecia Areata; Cyclobutanes; Cyclopropanes; Hair; Humans; Prognosis; Safety

1998
Topical immunotherapy in dermatology.
    International journal of clinical practice, 1999, Volume: 53, Issue:2

    Topics: Administration, Topical; Allergens; Alopecia Areata; Cyclobutanes; Cyclopropanes; Decision Making; Dinitrochlorobenzene; Humans; Immunotherapy; Warts

1999
Role of topical immunotherapy in the treatment of alopecia areata. Quality analysis of articles published between January 1977 and January 1988 about three treatments. Reading Group.
    Journal of the American Academy of Dermatology, 1990, Volume: 22, Issue:4

    Topics: Administration, Cutaneous; Alopecia Areata; Cyclobutanes; Cyclopropanes; Dinitrochlorobenzene; Humans; Immunotherapy; Meta-Analysis as Topic

1990
[Alopecia areata; pathogenesis and topical immunotherapy].
    Nederlands tijdschrift voor geneeskunde, 1989, Jun-24, Volume: 133, Issue:25

    Topics: Allergens; Alopecia Areata; Cyclobutanes; Cyclopropanes; Female; Humans; Male

1989

Trials

10 trial(s) available for squaric acid dibutyl ester and Alopecia Circumscripta

ArticleYear
Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): results of an open-label, paired-comparison, clinical trial.
    The Journal of dermatological treatment, 2005, Volume: 16, Issue:1

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Alopecia Areata; Analysis of Variance; Chi-Square Distribution; Child; Child, Preschool; Cyclobutanes; Female; Humans; Male; Middle Aged; Treatment Outcome

2005
Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in Alopecia areata and factors influencing the outcome.
    Journal of drugs in dermatology : JDD, 2006, Volume: 5, Issue:3

    Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adolescent; Adult; Alopecia Areata; Child; Cyclobutanes; Female; Humans; India; Male; Middle Aged; Severity of Illness Index; Treatment Outcome

2006
Topical squaric acid dibutylester therapy for alopecia areata.
    Cutis, 1982, Volume: 30, Issue:6

    Topics: Administration, Topical; Adolescent; Adult; Aged; Allergens; Alopecia Areata; Child; Clinical Trials as Topic; Cyclobutanes; Dermatitis, Contact; Female; Humans; Male; Middle Aged

1982
Contact allergy as a therapeutic tool for alopecia areata: application of squaric acid dibutylester.
    Dermatologica, 1980, Volume: 161, Issue:5

    Topics: Adolescent; Adult; Allergens; Alopecia Areata; Animals; Child; Cyclobutanes; Dermatitis, Contact; Dinitrochlorobenzene; Female; Guinea Pigs; Humans; Male; Middle Aged; Mutagens; Time Factors

1980
Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study.
    Annals of the Academy of Medicine, Singapore, 1996, Volume: 25, Issue:6

    Topics: Administration, Topical; Adolescent; Adult; Allergens; Alopecia Areata; Cyclobutanes; Double-Blind Method; Female; Follow-Up Studies; Hair; Humans; Immunotherapy; Male; Middle Aged; Prospective Studies; Time Factors

1996
Prognostic factors for clinical response of alopecia areata to topical immunotherapy with squaric acid dibutylester.
    Archives of dermatology, 1997, Volume: 133, Issue:4

    Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Child; Cyclobutanes; Female; Humans; Immunotherapy; Male; Middle Aged; Prognosis

1997
Treatment of alopecia areata with squaric acid dibutylester.
    Archives of dermatology, 1987, Volume: 123, Issue:8

    Topics: Allergens; Alopecia Areata; Clinical Trials as Topic; Cyclobutanes; Female; Hair; Humans; Male; Scalp Dermatoses

1987
[Controlled study of the efficacy of topical immunotherapy in alopecia areata: squaric acid versus placebo].
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 1987, Volume: 122, Issue:12

    Topics: Administration, Topical; Adolescent; Adult; Allergens; Alopecia Areata; Clinical Trials as Topic; Cyclobutanes; Drug Evaluation; Female; Humans; Male

1987
Therapies versus placebo in the treatment of patchy alopecia areata.
    Journal of the American Academy of Dermatology, 1986, Volume: 15, Issue:2 Pt 1

    Topics: Adolescent; Adult; Age Factors; Aged; Alopecia Areata; Child; Child, Preschool; Clinical Trials as Topic; Cyclobutanes; Cyclopropanes; Female; Humans; Male; Middle Aged; Minoxidil; Placebos

1986
Squaric acid dibutyl ester in the treatment of alopecia areata.
    Dermatologica, 1985, Volume: 170, Issue:1

    Topics: Adolescent; Adult; Alopecia Areata; Child; Clinical Trials as Topic; Cyclobutanes; Female; Humans; Male; Middle Aged

1985

Other Studies

60 other study(ies) available for squaric acid dibutyl ester and Alopecia Circumscripta

ArticleYear
Squaric acid dibutyl ester for the treatment of alopecia areata: A retrospective evaluation.
    Dermatologic therapy, 2021, Volume: 34, Issue:1

    Topics: Adult; Alopecia; Alopecia Areata; Cyclobutanes; Female; Humans; Immunotherapy; Male; Retrospective Studies

2021
Iatrogenic cutaneous lymphoid hyperplasia induced by squaric acid dibutyl ester.
    Contact dermatitis, 2021, Volume: 85, Issue:1

    Topics: Administration, Cutaneous; Allergens; Alopecia Areata; Cyclobutanes; Dermatitis, Allergic Contact; Humans; Hyperplasia; Iatrogenic Disease; Male; Middle Aged

2021
Therapeutic approach with squaric acid dibutylester for steroid resistant-alopecia areata incognita: A pilot study of a single center.
    Dermatologic therapy, 2021, Volume: 34, Issue:5

    Topics: Alopecia Areata; Cyclobutanes; Female; Humans; Pilot Projects; Steroids

2021
Immunotherapy for resistant and/or severe alopecia areata in a university hospital setting in Northern Mexico.
    The Australasian journal of dermatology, 2020, Volume: 61, Issue:1

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Cyclopropanes; Female; Hospitals, University; Humans; Immunotherapy; Male; Mexico; Middle Aged; Retrospective Studies; Young Adult

2020
Hapten-induced lymphadenosis benigna cutis secondary to squaric acid dibutylester sensitization for alopecia areata.
    The Journal of dermatology, 2014, Volume: 41, Issue:2

    Topics: Adult; Alopecia Areata; Choristoma; Cyclobutanes; Female; Haptens; Humans; Immunotherapy; Skin Diseases

2014
Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients.
    The Journal of dermatology, 2015, Volume: 42, Issue:1

    Topics: Adjuvants, Immunologic; Alopecia Areata; Cyclobutanes; Humans; Immunotherapy; Prospective Studies; Th1 Cells; Th17 Cells

2015
Squaric acid sensitization is not required for response in the treatment of alopecia areata.
    Journal of the American Academy of Dermatology, 2015, Volume: 73, Issue:3

    Topics: Administration, Topical; Adolescent; Adrenal Cortex Hormones; Adult; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Female; Follow-Up Studies; Hair; Humans; Immunization; Male; Retrospective Studies; Risk Assessment; Sampling Studies; Treatment Outcome; Young Adult

2015
Childhood epidermolysis bullosa acquisita during squaric acid dibutyl ester immunotherapy for alopecia areata.
    The British journal of dermatology, 2017, Volume: 176, Issue:2

    Topics: Alopecia Areata; Child; Cyclobutanes; Dermatologic Agents; Epidermolysis Bullosa Acquisita; Humans; Immunotherapy; Male

2017
Angioedema After Squaric Acid Treatment in a 6-Year-Old Girl.
    Pediatric dermatology, 2017, Volume: 34, Issue:1

    Topics: Adjuvants, Immunologic; Allergens; Alopecia Areata; Angioedema; Child; Cyclobutanes; Female; Humans

2017
Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases.
    The Journal of dermatology, 2009, Volume: 36, Issue:6

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Cyclopropanes; Dermatologic Agents; Female; Humans; Hypersensitivity; Immunotherapy; Male; Middle Aged; Retrospective Studies; Terfenadine; Young Adult

2009
Delayed type hypersensitivity-induced myeloid-derived suppressor cells regulate autoreactive T cells.
    European journal of immunology, 2011, Volume: 41, Issue:10

    Topics: Adaptor Proteins, Signal Transducing; Alopecia Areata; Animals; Apoptosis; Autoimmune Diseases; Autoimmunity; CD4-CD8 Ratio; Cell Differentiation; Cell Proliferation; Cells, Cultured; Cyclobutanes; Hypersensitivity, Delayed; Lymphocyte Activation; Mice; Mice, Inbred C3H; Mitochondria; Myeloid Cells; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Receptors, Antigen, T-Cell; Receptors, Tumor Necrosis Factor; Signal Transduction; T-Lymphocytes; Tretinoin; Tumor Necrosis Factor-alpha

2011
Alopecia areata triggered or exacerbated by swine flu virus infection.
    The Journal of dermatology, 2012, Volume: 39, Issue:10

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Alopecia Areata; Antiviral Agents; Child; Child, Preschool; Cyclobutanes; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Zanamivir

2012
Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
    The Journal of dermatology, 2002, Volume: 29, Issue:10

    Topics: Adjuvants, Immunologic; Administration, Oral; Administration, Topical; Adolescent; Adult; Alkaloids; Alopecia Areata; Benzylisoquinolines; Child; Combined Modality Therapy; Cryotherapy; Cyclobutanes; Female; gamma-Aminobutyric Acid; Humans; Immunotherapy; Male; Middle Aged

2002
The pattern and profile of alopecia areata in Singapore--a study of 219 Asians.
    International journal of dermatology, 2002, Volume: 41, Issue:11

    Topics: Adjuvants, Immunologic; Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Aged, 80 and over; Allergens; Alopecia Areata; Child; Child, Preschool; Cohort Studies; Cyclobutanes; Dermatitis, Atopic; Female; Humans; Immunotherapy; Incidence; Infant; Male; Middle Aged; Nail Diseases; Singapore; Surveys and Questionnaires

2002
Lentiginous eruption due to topical immunotherapy.
    Archives of dermatology, 2003, Volume: 139, Issue:4

    Topics: Adjuvants, Immunologic; Adolescent; Alopecia Areata; Cyclobutanes; Drug Eruptions; Humans; Lentigo; Male; Melanocytes

2003
Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata.
    Clinical and experimental immunology, 2004, Volume: 135, Issue:3

    Topics: Allergens; Alopecia Areata; Animals; Autoimmune Diseases; Cells, Cultured; Cyclobutanes; Hypersensitivity, Delayed; Immunophenotyping; Immunotherapy; Leukocytes; Lymph Nodes; Mice; Mice, Inbred C3H; Skin; T-Lymphocyte Subsets

2004
Prolonged dermatitis distant to the site of squaric acid dibutyl ester applications and recovery of alopecia areata.
    Clinical and experimental dermatology, 2005, Volume: 30, Issue:5

    Topics: Administration, Cutaneous; Adult; Alopecia Areata; Cyclobutanes; Drug Eruptions; Female; Humans

2005
A chronic contact eczema impedes migration of antigen-presenting cells in alopecia areata.
    The Journal of investigative dermatology, 2006, Volume: 126, Issue:7

    Topics: Alopecia Areata; Animals; Antigen-Presenting Cells; Cell Adhesion Molecules; Cell Movement; Chemokines; Chronic Disease; Cyclobutanes; Dendritic Cells, Follicular; Dermatitis, Contact; Female; Gene Expression Regulation; Hair Follicle; Leukocytes; Lymph Nodes; Mice; Mice, Inbred C3H; Receptors, Chemokine; Skin; T-Lymphocytes

2006
The importance of myeloid-derived suppressor cells in the regulation of autoimmune effector cells by a chronic contact eczema.
    Journal of immunology (Baltimore, Md. : 1950), 2007, Oct-15, Volume: 179, Issue:8

    Topics: Allergens; Alopecia Areata; Animals; Autoimmune Diseases; Chronic Disease; Cyclobutanes; Dermatitis, Contact; Down-Regulation; Hypersensitivity, Delayed; Membrane Proteins; Mice; Mice, Inbred C3H; Myeloid Cells; Receptors, Antigen, T-Cell; T-Lymphocytes, Regulatory

2007
Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.
    The Journal of dermatology, 2008, Volume: 35, Issue:3

    Topics: Adjuvants, Immunologic; Administration, Topical; Alopecia Areata; Cyclobutanes; Dermatitis, Contact; Humans; Lupus Erythematosus, Discoid; Male; Middle Aged

2008
[Squaric acid dibutyl ester in the treatment of severe alopecia areata].
    Medicina cutanea ibero-latino-americana, 1984, Volume: 12, Issue:3

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Alopecia Areata; Chemical Phenomena; Chemistry; Child; Child, Preschool; Cyclobutanes; Drug Evaluation; Female; Humans; Lymphatic Diseases; Male; Pigmentation Disorders

1984
Clinical experience on the treatment of alopecia areata with squaric acid dibutyl ester.
    Dermatologica, 1983, Volume: 167, Issue:5

    Topics: Adolescent; Adult; Allergens; Alopecia Areata; Child; Cyclobutanes; Female; Humans; Male; Middle Aged

1983
Topical therapy of alopecia areata with squaric acid dibutylester.
    Journal of the American Academy of Dermatology, 1984, Volume: 10, Issue:3

    Topics: Administration, Topical; Adult; Allergens; Alopecia Areata; Cyclobutanes; Dinitrochlorobenzene; Female; Humans; Immunotherapy; Male

1984
Topical immunotherapy in children with alopecia areata.
    The Journal of investigative dermatology, 1995, Volume: 104, Issue:5 Suppl

    Topics: Administration, Topical; Adolescent; Allergens; Alopecia Areata; Child; Cyclobutanes; Follow-Up Studies; Humans; Immunotherapy; Recurrence; Remission Induction

1995
Alopecia areata. A pathological study of nonresponder patients.
    The American Journal of dermatopathology, 1994, Volume: 16, Issue:2

    Topics: Adolescent; Adult; Alopecia Areata; Child; Cyclobutanes; Drug Resistance; Female; Humans; Male; Middle Aged; Skin

1994
Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients.
    Pediatric dermatology, 1994, Volume: 11, Issue:1

    Topics: Administration, Cutaneous; Adolescent; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Female; Follow-Up Studies; Hair; Humans; Lymphatic Diseases; Male; Recurrence

1994
Topical immunotherapy of alopecia areata.
    Dermatologic clinics, 1993, Volume: 11, Issue:3

    Topics: Administration, Topical; Allergens; Alopecia Areata; Cyclobutanes; Cyclopropanes; Hair; Humans; Immunotherapy

1993
Persistent allergic contact dermatitis at the site of primary sensitization with squaric acid dibutyl ester.
    Contact dermatitis, 1995, Volume: 33, Issue:6

    Topics: Adult; Allergens; Alopecia Areata; Cyclobutanes; Dermatitis, Allergic Contact; Female; Humans; Immunization; Immunotherapy

1995
Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis.
    Journal of the American Academy of Dermatology, 1996, Volume: 35, Issue:2 Pt 1

    Topics: Administration, Cutaneous; Adolescent; Allergens; Alopecia Areata; Autoantibodies; Child; Cyclobutanes; Female; Follow-Up Studies; Hair; Humans; Immunotherapy; Male; Recurrence; Treatment Outcome

1996
Treatment of alopecia areata with squaric acid dibutylester.
    International journal of dermatology, 1996, Volume: 35, Issue:1

    Topics: Adolescent; Adult; Allergens; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Dermatologic Agents; Female; Follow-Up Studies; Hair; Humans; Male; Middle Aged; Treatment Failure; Treatment Outcome

1996
Side-effects during treatment with SADBE.
    Contact dermatitis, 1997, Volume: 36, Issue:2

    Topics: Adult; Allergens; Alopecia Areata; Cyclobutanes; Dermatitis, Allergic Contact; Drug Eruptions; Humans; Male; Patch Tests

1997
Transient leucoderma appearing in an untreated area following contact immunotherapy for alopecia areata.
    European journal of dermatology : EJD, 1998, Volume: 8, Issue:2

    Topics: Adolescent; Alopecia Areata; Cyclobutanes; Female; Forehead; Humans; Hypopigmentation; Immunotherapy; Remission, Spontaneous

1998
Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
    The Journal of investigative dermatology, 1999, Volume: 113, Issue:1

    Topics: Allergens; Alopecia Areata; Animals; CD4-CD8 Ratio; Cyclobutanes; Dermis; Epithelium; Female; Hair; Hair Follicle; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Intercellular Adhesion Molecule-1; Lymphocytes; Male; Mice; Mice, Inbred C3H; Sebaceous Glands; Skin; Treatment Outcome

1999
Questions raised by skin reactions observed during squaric acid dibutyl ester contact sensitization.
    Contact dermatitis, 2000, Volume: 43, Issue:1

    Topics: Adjuvants, Immunologic; Allergens; Alopecia Areata; Cyclobutanes; Dermatitis, Allergic Contact; Diagnosis, Differential; Female; Forearm; Humans; Middle Aged; Patch Tests

2000
Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    European journal of dermatology : EJD, 2000, Volume: 10, Issue:6

    Topics: Adjuvants, Immunologic; Alopecia Areata; Animals; Cyclobutanes; Female; Hair; Hair Color; Hair Follicle; Male; Mice; Mice, Inbred C3H; Microscopy, Electron

2000
Squaric acid dibutylester: indications for use and efficacy in alopecia areata.
    Archives of dermatology, 2001, Volume: 137, Issue:7

    Topics: Administration, Topical; Adolescent; Adult; Age Distribution; Alopecia Areata; Autoimmune Diseases; Child; Cyclobutanes; Demography; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Retrospective Studies; Sample Size; Sex Distribution; Treatment Outcome

2001
Topical immunotherapy for alopecia areata: re-evaluation of 139 cases after an additional follow-up period of 19 months.
    Dermatology (Basel, Switzerland), 1992, Volume: 184, Issue:3

    Topics: Administration, Topical; Alopecia Areata; Cyclobutanes; Cyclopropanes; Follow-Up Studies; Humans; Immunotherapy; Male; Prognosis

1992
The loss of contact sensitization in man.
    Contact dermatitis, 1991, Volume: 24, Issue:3

    Topics: Administration, Topical; Adolescent; Adult; Aged; Alopecia Areata; Child; Cyclobutanes; Dermatitis, Contact; Dinitrochlorobenzene; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patch Tests

1991
Topical immunotherapy with contact allergens in alopecia areata: evidence for non-specific systemic suppression of cellular immune reactions.
    Archives of dermatological research, 1991, Volume: 283, Issue:2

    Topics: Administration, Cutaneous; Adolescent; Adult; Allergens; Alopecia Areata; Cyclobutanes; Cyclopropanes; Female; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunotherapy; Male; Middle Aged

1991
Erythema multiforme-like eruptions: a rare side effect of topical immunotherapy with diphenylcyclopropenone.
    Dermatologica, 1990, Volume: 180, Issue:1

    Topics: Administration, Topical; Adult; Alopecia Areata; Cyclobutanes; Cyclopropanes; Drug Eruptions; Erythema Multiforme; Female; Humans; Middle Aged

1990
Photochemotherapy plus squaric acid dibutylester in alopecia areata treatment.
    Dermatologica, 1990, Volume: 181, Issue:2

    Topics: Adult; Alopecia Areata; Cyclobutanes; Female; Humans; Middle Aged; PUVA Therapy

1990
Alopecia areata: more on topical sensitizers.
    Dermatologica, 1990, Volume: 180, Issue:2

    Topics: Administration, Topical; Alopecia Areata; Cyclobutanes; Female; Humans; Prognosis; Psoriasis

1990
Topical immunotherapy of alopecia areata. A follow-up study.
    Acta dermato-venereologica, 1986, Volume: 66, Issue:3

    Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Child; Cyclobutanes; Dinitrochlorobenzene; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitrobenzenes; Recurrence

1986
Immunohistological evaluation of alopecia areata treated with squaric acid dibutylester (SADBE).
    Acta dermato-venereologica, 1986, Volume: 66, Issue:6

    Topics: Adolescent; Adult; Alopecia Areata; B-Lymphocytes; Complement C3; Cyclobutanes; Female; Fibrin; Fluorescent Antibody Technique; Humans; Immunoglobulins; Male; Middle Aged; T-Lymphocytes

1986
Thymopentin in the treatment of alopecia areata.
    Dermatologica, 1989, Volume: 178, Issue:4

    Topics: Adjuvants, Immunologic; Alopecia Areata; Cyclobutanes; Drug Therapy, Combination; Humans; Injections, Intradermal; Injections, Intravenous; Peptide Fragments; Thymopentin; Thymopoietins; Thymus Hormones

1989
Contact urticaria during topical immunotherapy.
    Contact dermatitis, 1989, Volume: 21, Issue:3

    Topics: Administration, Topical; Adult; Alopecia Areata; Cyclobutanes; Cyclopropanes; Dermatitis, Contact; Dinitrochlorobenzene; Female; Humans; Immunotherapy; Male; Urticaria

1989
Thymopentin in the treatment of severe alopecia areata.
    Dermatologica, 1988, Volume: 177, Issue:3

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Alopecia Areata; Cyclobutanes; Cyclopropanes; Female; Humans; Male; Middle Aged; Peptide Fragments; Thymopentin; Thymopoietins; Thymus Hormones

1988
[Sensitization therapy in severe alopecia areata].
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 1988, Volume: 123, Issue:11

    Topics: Adolescent; Adult; Aged; Allergens; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Cyclopropanes; Female; Humans; Immunization; Male; Middle Aged

1988
[In situ lymphocyte subpopulation in alopecia areata after treatment with squaric acid dibutyl ester].
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 1988, Volume: 123, Issue:11

    Topics: Adolescent; Adult; Allergens; Alopecia Areata; Child; Cyclobutanes; Female; Humans; Lymphocytes; Male; Middle Aged; Time Factors

1988
Decreased in vitro lymphocyte stimulation and reduced sensitivity to IL-2 in patients with alopecia areata.
    Archives of dermatological research, 1988, Volume: 280 Suppl

    Topics: Administration, Cutaneous; Adolescent; Adult; Alopecia Areata; Child; Concanavalin A; Cyclobutanes; HLA-DR Antigens; Humans; In Vitro Techniques; Interleukin-2; Lymphocyte Activation; Middle Aged; Phytohemagglutinins

1988
Percutaneous penetration of squaric acid and its esters in hairless mouse and human skin in vitro.
    Archives of dermatological research, 1988, Volume: 280, Issue:1

    Topics: Allergens; Alopecia Areata; Animals; Cyclobutanes; Female; Humans; In Vitro Techniques; Mice; Mice, Hairless; Skin

1988
Patterns of hair regrowth in alopecia areata.
    Dermatologica, 1988, Volume: 176, Issue:5

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Alopecia Areata; Child; Cyclobutanes; Cyclopropanes; Female; Hair; Humans; Male; Minoxidil

1988
Unusual complication of sensitizing therapy for alopecia areata.
    Contact dermatitis, 1988, Volume: 18, Issue:5

    Topics: Acetone; Adult; Alopecia Areata; Cyclobutanes; Dermatitis, Contact; Female; Humans

1988
Squaric acid dibutylester in alopecia areata: is discomfort really necessary?
    Journal of the American Academy of Dermatology, 1987, Volume: 16, Issue:4

    Topics: Alopecia Areata; Cyclobutanes; Humans

1987
[Topical therapy of alopecia areata with squaric acid dibutyl ester].
    Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology, 1987, Volume: 97, Issue:1

    Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Drug Evaluation; Female; Humans; Infant; Male; Middle Aged

1987
Alopecia areata and measles.
    Journal of the American Academy of Dermatology, 1987, Volume: 17, Issue:5 Pt 1

    Topics: Alopecia Areata; Child; Cyclobutanes; Hair; Humans; Male; Measles

1987
Squaric acid esters in the treatment of alopecia areata.
    Journal of the American Academy of Dermatology, 1986, Volume: 14, Issue:5 Pt 1

    Topics: Allergens; Alopecia Areata; Cyclobutanes; Humans

1986
Squaric acid dibutylester treatment of alopecia areata.
    Clinical and experimental dermatology, 1985, Volume: 10, Issue:3

    Topics: Adolescent; Adult; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Dermatitis, Contact; Female; Humans; Male; Middle Aged

1985
Nickel sensitivity as a complication of squaric acid dibutylester treatment of alopecia areata.
    Contact dermatitis, 1985, Volume: 12, Issue:4

    Topics: Adult; Allergens; Alopecia Areata; Cyclobutanes; Dermatitis, Contact; Female; Humans; Nickel

1985
Squaric acid and esters: analysis for contaminants and stability in solvents.
    Journal of the American Academy of Dermatology, 1985, Volume: 13, Issue:2 Pt 1

    Topics: Alopecia; Alopecia Areata; Butadienes; Carcinogens; Cyclobutanes; Gas Chromatography-Mass Spectrometry; Humans; Hydrolysis

1985